Abstract:Background & aims: The nuclear receptor subfamily 0 group B member 2 (NR0B2, also called SHP) is expressed at high levels in the liver and intestine. Postprandial fibroblast growth factor 19 (human FGF19, mouse FGF15) signaling increases the transcriptional activity of SHP. We studied the functions of SHP and FGF19 in the intestines of mice, including their regulation of expression of the cholesterol transporter NPC1L1 )NPC1-like intracellular cholesterol transporter 1) and cholesterol absorption. Methods: We performed histologic and biochemical analyses of intestinal tissues from C57BL/6 and SHP-knockout mice and performed RNA-sequencing analyses to identify genes regulated by SHP. The effects of fasting and refeeding on intestinal expression of NPC1L1 were examined in C57BL/6, SHP-knockout, and FGF15-knockout mice. Mice were given FGF19 daily for 1 week; fractional cholesterol absorption, cholesterol and bile acid (BA) levels, and composition of BAs were measured. Intestinal organoids were generated from C57BL/6 and SHP-knockout mice, and cholesterol uptake was measured. Luciferase reporter assays were performed with HT29 cells. Results: We found that the genes that regulate lipid and ion transport in intestine, including NPC1L1, were up-regulated and that cholesterol absorption was increased in SHP-knockout mice compared with C57BL/6 mice. Expression of NPC1L1 was reduced in C57BL/6 mice after refeeding after fasting but not in SHP-knockout or FGF15-knockout mice. SHP-knockout mice had altered BA composition compared with C57BL/6 mice. FGF19 injection reduced expression of NPC1L1, decreased cholesterol absorption, and increased levels of hydrophilic BAs, including tauro-α- and -β-muricholic acids; these changes were not observed in SHP-knockout mice. SREBF2 (sterol regulatory element binding transcription factor 2), which regulates cholesterol, activated transcription of NPC1L1. FGF19 signaling led to phosphorylation of SHP, which inhibited SREBF2 activity. Conclusions: Postprandial FGF19 and SHP inhibit SREBF2, which leads to repression of intestinal NPC1L1 expression and cholesterol absorption. Strategies to increase FGF19 signaling to activate SHP might be developed for treatment of hypercholesterolemia.

The Clathrin Adaptor Numb Regulates Intestinal Cholesterol Absorption Through Dynamic Interaction with NPC1L1.

Numb Modulates the Paracellular Permeability of Intestinal Epithelial Cells Through Regulating Apical Junctional Complex Assembly and Myosin Light Chain Phosphorylation.

The N-Terminal Domain of Npc1l1 Protein Binds Cholesterol and Plays Essential Roles in Cholesterol Uptake

Effect of Hepatic NPC1L1 on Cholesterol Gallstone Disease and Its Mechanism

The n-terminal domain of npc 1 l 1 binds cholesterol and plays essential roles in cholesterol uptake

The Cholesterol Absorption Inhibitor Ezetimibe Acts by Blocking the Sterol-Induced Internalization of NPC1L1

Niemann-Pick C1-Like 1 inhibitors for reducing cholesterol absorption

Fluorescent visualization and evaluation of NPC1L1-mediated vesicular endocytosis during intestinal cholesterol absorption in mice

Flotillins Play an Essential Role in Niemann-Pick C1-Like 1-Mediated Cholesterol Uptake

NPC1L1 inhibition disturbs lipid trafficking and induces large lipid droplet formation in intestinal absorptive epithelial cells

Membrane Topology Of Human Npc1l1, A Key Protein In Enterohepatic Cholesterol Absorption

Inter-domain dynamics drive cholesterol transport by NPC1 and NPC1L1 proteins

Structural insights into the mechanism of human NPC1L1-mediated cholesterol uptake

Small Heterodimer Partner and Fibroblast Growth Factor 19 Inhibit Expression of NPC1L1 in Mouse Intestine and Cholesterol Absorption

NPC1L1 Facilitates Sphingomyelin Absorption and Regulates Diet-Induced Production of VLDL/LDL-associated S1P

Requirement of Myosin Vb·Rab11a·Rab11-FIP2 Complex in Cholesterol-regulated Translocation of NPC1L1 to the Cell Surface

Aster-dependent nonvesicular transport facilitates dietary cholesterol uptake

Fatty Acids Modulate the Expression Levels of Key Proteins for Cholesterol Absorption in Caco-2 Monolayer

Cryo-EM structures of NPC1L1 reveal mechanisms of cholesterol transport and ezetimibe inhibition

NPC1L1 Plays a Novel Role in Nonalcoholic Fatty Liver Disease

Molecular Characterization of the NPC1L1 Variants Identified from Cholesterol Low Absorbers